Press Releases
GERMANTOWN, Md., Oct. 25, 2026 (GLOBE NEWSWIRE) -- AirTripMaker, a growing travel platform focused on connecting travelers with convenient international air travel options, is expanding its USA and Canada to India travel network to serve passengers traveling from the United States or Canada to India’s most important metropolitan, business, technology, cultural and tourism destinations.
In 2026, finding a “deal” to India is no longer just about price—it’s about... (continue reading...)
- Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk of death (HR 0.69; 95% CI 0.54–0.89; one-sided P = 0.0021).
- The 2-year OS rate was 54.1% vs 37.2%, an improvement of 16.9%; with a median follow-up of 32.3 months, the survival benefit was sustained.
- The adjusted median OS differed by 9.3 months (25.9 vs 16.6... (continue reading...)
- The cohort met its primary endpoint of major pathologic response, with 83% of patients having little or no cancer remaining at surgery in a high-risk, locally advanced population
- Side effects were mostly mild and manageable, and all 18 patients proceeded to surgery
- Netherlands Cancer Institute investigators are now enrolling a rectal cancer cohort to evaluate whether a short course of botensilimab and balstilimab can allow patients to avoid surgery
Enterprise TRiSCM™ innovator advances Continuous Control Assurance, cyber risk quantification and real-time Risk Operations across global enterprises, transforming traditional GRC into proactive Digital Trust
DALLAS, Oct. 25, 2026 /PRNewswire/ -- DigitalXForce, the AI-native Enterprise Trust, Risk, Security and Compliance Management (TRiSCM™) platform, today announced the continued global rollout of X-ROC™ (XForce Risk Operations... (continue reading...)
- Updated Phase 1b dataset provides nearly 18 months of median follow-up and shows the durability of clinical benefit observed with givastomig
- Clinical activity observed across CLDN18.2 expression levels, including in patients with lower-expression tumors not eligible for currently approved CLDN18.2-targeted therapies
- Totality of efficacy, safety and long-term follow-up data supports selection of the 8 mg/kg dose for registrational development
- Ongoing U.S. Food and Drug... (continue reading...)
More Press Releases
View Older Stories-
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
-
Binance Acquires BTEXCHAIN, Accelerating the Integration of AI and Global Digital Asset Trading Technology
-
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
-
Best AI Tools for Small Business Marketing (2026): CapCut Featured for Creating Professional Video and Visual Content by Expert Consumers
-
Beyond Live Streaming: Tango Gives Back by Supporting Cancer Detection in Ukraine
-
Borr Drilling Limited - Prospector 5 Rig Incident
-
SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America)
-
Best Broadband Provider for Small Businesses UK (2026): Love Business Group Recognised for Helping SMEs Compare Business Broadband Options by Expert Consumers
-
Best Protective iPhone Cases for 2026: Top Slim and Drop-Protection Options for iPhone 18 Pro & iPhone 18 Pro Max Recommended by Consumer365
-
Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
-
KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients
-
Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and
-
Cryptocurrency News: Solana Goes 85x Faster as Pepeto Early Buyers Line Up for a Run
-
Bitcoin Price News Today: BTC Holds $81K After a $406M Wipeout While Pepeto Buyers Line Up
-
Frontier Medicines Presents Promising Anti-Tumor Activity from Phase 1/2 PROSPER Trial of FMC-376 in a Highly Resistant Patient Population of KRAS G12C-Mutant NSCLC at ESMO 2026
-
Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
-
New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
-
BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
-
Binance Coin Price Holds $730 After 1.6M Burn as Buyers Bet Pepeto Can Be the Next BNB
-
Next Crypto to Make You Rich: Pepeto’s Call Pulls Buyers Away From XRP and Cardano
-
XRP Price Prediction: Patient Holders Wait on $1.49 as Pepeto Buyers Chase Returns Before Listing
-
Dogecoin Price Prediction: New Dogecoin Labs Could Lift DOGE From $0.08, but Pepeto Looks Like Early DOGE
-
How to Market a Dental Business Online to Improve Visibility on Search Engines and AI Search
-
BNB Price Prediction: A $1.2 Billion Burn Draws Interest, and Analysts Map a Run for Pepeto
-
New Cryptocurrency Picks This Week: Can Solana or Zcash Match the Gains Analysts See in Pepeto?
-
Top Custom and OEM Security Camera Manufacturers for Project-Based Deployments.
-
New Creative Resource Helps Teams Plan AI Video and Image Workflows More Effectively
-
Cryptocurrency News: $431M in Bets Wiped Out in a Day as Pepeto Buyers Chase Gains Like Ethereum’s First Holders
-
Cardano Price Prediction: ADA at $0.22 vs Pepeto, the Showdown Where Analysts See a Run
-
Solana Price Prediction: JPMorgan Brings Two Funds to Solana as Analysts Say Pepeto Could Explode
-
Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026
-
Solana Price Drops Over 2% Despite Upgrade as SOL Whales Rush Into AlphaPepe Presale For 200x
-
Hometown Supply Simplifies Impact Windows and Sliding Glass Doors in Southwest Florida
-
Chicago Family Business Continues to Challenge Big Insurance Nationwide
-
Chris Gibson Announces 1M YouTube Milestone
-
Bridger Hat Co Launches Faith-Forward Ball Cap Line With a Scripture Reference Stitched Inside Every Crown
-
2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC
-
2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer
-
Best Crypto Presale: AlphaPepe Challenges the Bitcoin, Ethereum and XRP Trade With a Working AI Product
-
Bitcoin Price Prediction: BTC Below $80K Next? AlphaPepe Adds 100+ Holders Daily Despite Iran War Fears
-
ST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East
-
Solana Price Prediction: SOL Could Hit $150 After Its Biggest Upgrade, but Pepeto Draws Talk
-
ADA Price Prediction: Cardano Opens Its Dijkstra Testnet at $0.22, While Pepeto Buyers Chase a Pepe Repeat
-
HKA Enterprises is Powering the Skilled Trades That Are Moving the U.S. Economy Forward
-
New Guide Titled "Gold Proof Coins vs Uncirculated Coins: Are Gold Proof Coins a Good Investment" Released
-
Expo Contratista Announces 10th Edition in Dallas, Spotlighting Latino Construction Businesses and Workforce Development
-
Prospera Energy Announces Service Rig Update as Luseland Workovers Come Online at 3.3x Prior Rates
-
Crypto Market News: BlackRock Files 3rd Bitcoin ETF, and Pepeto Buyers Chase a Shiba Inu Style Run
-
Best Crypto to Buy in October 2026: Solana, BNB, and the Pepeto Presale Buyers Keep Rushing Into
-
Bitcoin Price Today Holds $81K as PEPE Jumps 13%, and Pepeto Draws Buyers Chasing a Shot


